A Martin Lerner

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from Martin Lerner)
Jump to: navigation, search
Source: treatmentcenterforcfs.com

Dr. A. Martin Lerner, aka Martin Lerner, (d. 2015) was a much beloved and respected Myalgic Encephalomyelitis/Chronic Fatigue Syndrome specialist who died in October 2015, at the age of 86.[1]

He was one of the experts on the "Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome" that was convened for the 2015 Institute of Medicine report,[2] as well as, one of the authors of the 2003 Canadian Consensus Criteria for Myalgic Encephalomyelitis, published as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome:Clinical Working Case Definition,Diagnostic and Treatment Protocols[3]

He was a strong advocate of using antivirals because he hypothesized CFS is caused by 3 herpesviruses: Epstein-Barr virus, cytomegalovirus and/or Human herpesvirus 6. "These three viruses establish “latent” infection in B-lymphocytes, monocyte-macrophage precursors, or T-lymphocytes respectively. Virus reactivation, and both abortive and complete virus multiplication occur. Therefore CFS patients have been described with continuing primary or reactivated infections.[4]

Notable studies in ME/CFS[edit | edit source]

Talks and interviews[edit | edit source]

Talks on Lerner's webpage[edit | edit source]

  • August 22, 2007 – Dr. A Martin Lerner presenting Medical Grand Rounds at William Beaumont Hospital in Royal Oak, MI on the Topic of Chronic Fatigue Syndrome. - (Video)
  • May 23, 2008 – Dr. A Martin Lerner’s presentation on The Sub-grouping & Treatment for ME/CFS, at the 3rd annual Invest in ME International ME/CFS Conference in London, England. - (Video)
  • October 12, 2010 – Dr. A Martin Lerner’s presentation on Successful Antiviral Treatment of CFS and Its Science at the CFSAC biannual meeting hosted by the Department of Health and Human Services in Washington, DC. - (Video)
  • August 20, 2011, Part 1 – Dr. A Martin Lerner presenting at William Beaumont Hospital in Royal Oak, MI to infectious disease physicians in Michigan "A Primer on ME/CFS -Background, Virology, Immunology, Pathologic Physiology, Diagnosis and Treatment." - (Video); PDF Download of presentation slides; PDF Download of ME/CFS Treatment Resource Guide for Practitioners
  • August 20, 2011, Part 2 – Dr. A Martin Lerner presenting at William Beaumont Hospital in Royal Oak, MI to infectious disease physicians in Michigan "A Primer on ME/CFS -Background, Virology, Immunology, Pathologic Physiology, Diagnosis and Treatment." - (Video); PDF Download of presentation slides; PDF Download of ME/CFS Treatment Resource Guide for Practitioners

Invest in ME International ME Conference[edit | edit source]

  • 2008, Speaker at the 3rd Invest in ME International ME Conference on Diagnosis and Treatment of ME/CFS - Longitudinal Observations of Cardiac and Antiviral studies[7] - (Video)

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. http://www.irakaufman.com/mobile/detail.php?id=5990
  2. Syndrome, Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue; Populations, Board on the Health of Select; Medicine, Institute of (Feb 10, 2015). Biographical Sketches of Committee Members, Consultants, and Staff. National Academies Press (US). 
  3. http://phoenixrising.me/wp-content/uploads/Canadian-definition.pdf
  4. "http://treatmentcenterforcfs.com/personal_statement/index.html
  5. Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, A C Peter; Sherkey, Jeffrey A.; van de Sande, Marjorie I. (2003), "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols" (PDF), Journal of Chronic Fatigue Syndrome, 11 (2): 7-115, doi:10.1300/J092v11n01_02 
  6. Lerner, AM; Ariza, ME; Williams, M; Jason, L; Beqaj, S; Fitzgerald, JT; Lemeshow, S; Glaser, R (2012), "Antibody to Epstein-Barr Virus Deoxyuridine Triphosphate Nucleotidohydrolase and Deoxyribonucleotide Polymerase in a Chronic Fatigue Syndrome Subset", PLoS ONE, 7 (11): e47891, doi:10.1371/journal.pone.0047891 
  7. http://www.investinme.org/IIMEC3.shtml#agenda

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

ME/CFS - An acronym that combines myalgic encephalomyelitis with chronic fatigue syndrome. Sometimes they are combined because people have trouble distinguishing one from the other. Sometimes they are combined because people see them as synonyms of each other.

antibody - Antibodies or immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.

Chronic Fatigue Syndrome Advisory Committee (CFSAC) - (sometimes pronounced SIF-SACK) A US government advisory council that met twice per year, covering current topics related to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Meetings usually lasted for two days and the results were presented to the Secretary of Health and Human Services (HHS). After 15 years, on September 5, 2018, CFSAC's charter was not renewed by the Department of HHS, effectively dissolving the committee without notice or warning.

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.